Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07300982) titled 'Studies of Insulin and Glucagon Action in the Liver' on Dec. 22, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Single (Participant).

Primary Sponsor: Duke University

Condition: Diabetes (DM)

Intervention: Drug: Glucagon

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: April 2026

Target Sample Size: 40

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07300982

Published by HT Digital Content Services with permission...